Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 3/20 | 0.38 |
| ▸ | ANPEP | P15144 | 2/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TGM2 | P21980 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6184330 | 1.00 | NR1H2 (0.40) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL9601879 | 1.00 | NR1H2 (0.40) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL17317642 | 1.00 | NR1H2 (0.40) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL29851070 | 0.89 | NR1H2 (0.40) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL6185885 | 0.89 | NR1H2 (0.40) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL31000687 | 0.89 | NR1H2 (0.40) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL2708302 | 0.86 | NR1H2 (0.51) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL18829250 | 0.86 | NR1H2 (0.51) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL15815897 | 0.86 | NR1H2 (0.41) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 | |
| SCHEMBL2708360 | 0.86 | NR1H2 (0.41) | NR1H2MMP2ANPEPNR1H3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10144732-B2 | ATX modulating agents | BIOGEN MA INC. (US) | 2018-12-04 | — | — | US | disclosed |
| US-20170197960-A1 | ATX MODULATING AGENTS | BIOGEN MA INC. | 2017-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197960-A1 | ATX MODULATING AGENTS | ENPP2, ATXN10, ATXN2 | NR1H2 1523/4885MMP2 1004/4885ANPEP 1858/4885 |
| US-10144732-B2 | ATX modulating agents | ENPP2, ATXN10, ATXN2 | NR1H2 1524/4885MMP2 1003/4885ANPEP 1859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.